The M-CSF/CSF-1R, CCL2/CCR2, CCL5/CCR5, and CX3CL1/CX3CR1 pathways discussed above are the main targets that show potential in tumor therapy (142). This evidence concerns the gene CX3CR1 and neoplasm.